Pirkko Härkönen

7.9k total citations
140 papers, 6.4k citations indexed

About

Pirkko Härkönen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Pirkko Härkönen has authored 140 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 52 papers in Oncology and 33 papers in Genetics. Recurrent topics in Pirkko Härkönen's work include Estrogen and related hormone effects (30 papers), Fibroblast Growth Factor Research (29 papers) and Bone health and treatments (23 papers). Pirkko Härkönen is often cited by papers focused on Estrogen and related hormone effects (30 papers), Fibroblast Growth Factor Research (29 papers) and Bone health and treatments (23 papers). Pirkko Härkönen collaborates with scholars based in Finland, Sweden and United States. Pirkko Härkönen's co-authors include H. Kalervo Väänänen, Eeva Valve, Husheem Michael, Marja T. Nevalainen, Sari Mäkelä, Johanna Ruohola, Ammar Saleem, Kalevi Pihlaja, Johanna Tuomela and Kari Alitalo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature reviews. Cancer.

In The Last Decade

Pirkko Härkönen

140 papers receiving 6.1k citations

Peers

Pirkko Härkönen

ONCOL

GENET

PRM

Hirotoshi Tanaka Japan

Ralph Buttyan United States

Lothar Schweigerer Germany

Hung‐Yun Lin United States

Ulrich Pfeffer Italy

Jean‐Claude Chambard France

Zafar Nawaz United States

Yutaka Kohgo Japan

Natasha Kyprianou United States

Matías A. Ávila Spain

Hirotoshi Tanaka Japan

Pirkko Härkönen

4.2k ×1.3

1.2k ×0.6

ONCOL

1.0k ×0.8

GENET

1.9k ×2.1

539 ×0.6

PRM

Citations per year, relative to Pirkko Härkönen Pirkko Härkönen (= 1×) peers Hirotoshi Tanaka

Countries citing papers authored by Pirkko Härkönen

Since Specialization

Citations

This map shows the geographic impact of Pirkko Härkönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pirkko Härkönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pirkko Härkönen more than expected).

Fields of papers citing papers by Pirkko Härkönen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pirkko Härkönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pirkko Härkönen. The network helps show where Pirkko Härkönen may publish in the future.

Co-authorship network of co-authors of Pirkko Härkönen

This figure shows the co-authorship network connecting the top 25 collaborators of Pirkko Härkönen. A scholar is included among the top collaborators of Pirkko Härkönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pirkko Härkönen. Pirkko Härkönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Lan, Mervi Toriseva, Vidal Fey, et al.. (2022). Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression. Cancers. 14(2). 278–278. 5 indexed citations

Polari, Lauri, Sofia Sousa, Lauri Kangas, et al.. (2018). SERMs Promote Anti-Inflammatory Signaling and Phenotype of CD14+ Cells. Inflammation. 41(4). 1157–1171. 19 indexed citations

Vainio, Minna, et al.. (2014). Adenosine Inhibits Tumor Cell Invasion via Receptor-Independent Mechanisms. Molecular Cancer Research. 12(12). 1863–1874. 44 indexed citations

Tuomela, Johanna, Jouko Sandholm, Peeter Karihtala, et al.. (2012). Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer. Breast Cancer Research and Treatment. 135(2). 481–493. 58 indexed citations

Čulig, Zoran, et al.. (2010). Role of the protein tyrosine phosphatase SHP‐1 in Interleukin‐6 regulation of prostate cancer cells. The Prostate. 70(14). 1491–1500. 22 indexed citations

Lehn, Sophie, Nicholas P. Tobin, Pontus Berglund, et al.. (2010). Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features. American Journal Of Pathology. 177(6). 2886–2897. 54 indexed citations

Tuomela, Johanna, et al.. (2009). Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors. BMC Cancer. 9(1). 362–362. 24 indexed citations

Brokken, Leon J. S., Karin Jirström, Roy Ehrnström, et al.. (2009). Immunohistochemical detection of tyrosine phosphatase SHP‐1 predicts outcome after radical prostatectomy for localized prostate cancer. International Journal of Cancer. 126(10). 2296–2307. 27 indexed citations

Säfholm, Annette, et al.. (2008). The Wnt-5a–Derived Hexapeptide Foxy-5 Inhibits Breast Cancer Metastasis In vivo by Targeting Cell Motility. Clinical Cancer Research. 14(20). 6556–6563. 109 indexed citations

10.

Valtonen‐André, Camilla, Anders Bjartell, Rebecka Hellsten, et al.. (2007). A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue. Biological Chemistry. 388(3). 289–95. 18 indexed citations

11.

Mattila, Mirjami, Tiina Laitala‐Leinonen, Kálman G. Büki, et al.. (2006). Fibroblast growth factor 8 induces osteoclast differentiation in vitro and increases experimental bone metastasis of MDA-MB-231 breast cancer cells in vivo in nude mice. Cancer Research. 66. 935–935. 1 indexed citations

12.

Junttila, Teemu T., Maria Sundvall, Mikael Lundin, et al.. (2005). Cleavable ErbB4 Isoform in Estrogen Receptor–Regulated Growth of Breast Cancer Cells. Cancer Research. 65(4). 1384–1393. 159 indexed citations

13.

Väänänen, H. Kalervo, et al.. (2004). Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply. Cancer Research. 64(8). 2935–2936. 17 indexed citations

14.

Santti, Risto, et al.. (2004). Sex specific expression of progesterone receptor in mouse lower urinary tract. Molecular and Cellular Endocrinology. 230(1-2). 17–21. 17 indexed citations

15.

Ahonen, Tommi J., Pirkko Härkönen, Hallgeir Rui, & Marja T. Nevalainen. (2002). PRL Signal Transduction in the Epithelial Compartment of Rat Prostate Maintained as Long-Term Organ Cultures in Vitro. Endocrinology. 143(1). 228–238. 52 indexed citations

16.

Valve, Eeva, et al.. (2001). Expression of the androgen-dependent MMTV-specific orf gene in Shionogi 115 mouse mammary tumor cells. The Journal of Steroid Biochemistry and Molecular Biology. 78(5). 389–400. 1 indexed citations

17.

Nevalainen, Marja T., Eeva Valve, P.M. Ingleton, et al.. (1997). Prolactin and prolactin receptors are expressed and functioning in human prostate.. Journal of Clinical Investigation. 99(4). 618–627. 162 indexed citations

18.

Wärri, Anni, Jorma Isola, & Pirkko Härkönen. (1996). Anti-oestrogen stimulation of ERBB2 ectodomain shedding from BT-474 human breast cancer cells with ERBB2 gene amplification. European Journal of Cancer. 32(1). 134–140. 7 indexed citations

19.

Corbier, P., et al.. (1995). Experimental Research on the Morphofunctional Differentiation of the Rat Ventral Prostate: Roles of the Gonads at Birth. Archives of Physiology and Biochemistry. 103(6). 699–714. 11 indexed citations

20.

Leppä, Sirpa, Pirkko Härkönen, & Markku Jalkanen. (1991). Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.. PubMed. 2(1). 1–11. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact